BioTiGR is proud to announce that Camille Roussel, has been selected by the American Society of Hematology (ASH) to participate as one of eight outstanding recipients in the 2025 ASH Global Research Award, part of ASH’s investment hematology research and the next generation of hematology physicians and scientists.

Through this award, Camille Roussel will receive funding to support her project on Hereditary Spherocytosis.